BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3767617)

  • 1. [Anti-aggregant and anticoagulant effects of oligoamines. II. P-phenylenebis(alkanamines)].
    Rehse K; Lükens U
    Arch Pharm (Weinheim); 1986 Jul; 319(7):603-7. PubMed ID: 3767617
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-aggregation and anticoagulant effects of oligoamines. 3. M-phenylenebisaminoalkanes].
    Rehse K; Lükens U; Leissring S; Claus G
    Arch Pharm (Weinheim); 1987 Mar; 320(3):228-33. PubMed ID: 3579524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiaggregatory and anticoagulant effects of oligoamines. 5. Alicyclic di- and triamines].
    Rehse K; Carstensen A; Ernst HJ
    Arch Pharm (Weinheim); 1987 Sep; 320(9):829-36. PubMed ID: 3675171
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-aggregatory and anticoagulant effects of oligoamines. 6. Oligohydroxyalkane diamines].
    Rehse K; Claus G; Leissring S
    Arch Pharm (Weinheim); 1987 Nov; 320(11):1155-61. PubMed ID: 3439860
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiaggregatory and anticoagulant actions of oligoamines. 1. 4-Piperidinylmethaneamines].
    Rehse K; Werner U
    Arch Pharm (Weinheim); 1986 Jun; 319(6):505-15. PubMed ID: 3090975
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-aggregatory and anticoagulant properties of oligoamines. 11. Oligoamines with two primary amine groups].
    Rehse K; Rose B; Leissring S
    Arch Pharm (Weinheim); 1990 Feb; 323(2):103-8. PubMed ID: 2334273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiaggregatory and anticoagulant effects of oligoamines. 7. Benzene-1,3,5-trialkaneamines].
    Rehse K; Lükens U; Claus G
    Arch Pharm (Weinheim); 1987 Dec; 320(12):1233-8. PubMed ID: 3439865
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, Part 33. From tetradecane- to octacosanediamines.
    Rehse K; Nolte-Driller R
    Arch Pharm (Weinheim); 1996 Apr; 329(4):191-6. PubMed ID: 8669983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiaggregatory and anticoagulant effects of oligoamines. 4. N,N'-Bisarylalkylalkanediamines].
    Rehse K; Carstensen A; Ernst HJ
    Arch Pharm (Weinheim); 1987 Aug; 320(8):724-9. PubMed ID: 3675165
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-aggregatory and anticoagulant effects of oligoamines. 9. The pharmacokinetics of N,N',N"-tris-4-(3-iodo-4-methoxyphenyl)-butyl-1,3,5-benzene triethanamine].
    Rehse K; Buck W; Wenzel M
    Arch Pharm (Weinheim); 1988 Nov; 321(11):813-6. PubMed ID: 3219050
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiaggregative and anticoagulant effects of oligoamines. 8. Oligoamines with N-heterocyclic space structures].
    Rehse K; Mletzko S
    Arch Pharm (Weinheim); 1988 Sep; 321(9):533-6. PubMed ID: 3240067
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiaggregatory and anticoagulant effects of oligoamines. 12. Alkyl- and arylalkyl- derivatives of putrescine, spermidine and spermine].
    Rehse K; Puchert E; Leissring S
    Arch Pharm (Weinheim); 1990 May; 323(5):287-94. PubMed ID: 2383171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiaggregatory and anticoagulant effects of oligoamines. 10. Tertiary oligoamines and quaternary ammonium salts].
    Rehse K; Kämpfe M
    Arch Pharm (Weinheim); 1989 Nov; 322(11):811-5. PubMed ID: 2624527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanidinophenyl derivatives of pyrazole: synthesis and inhibitory effect on serine proteinases, blood coagulation and platelet aggregation.
    Ferroni R; Menegatti E; Scalia S; Orlandini P; Guarneri M; Taddeo U
    Farmaco Sci; 1986 Oct; 41(10):747-57. PubMed ID: 3539635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVII: Oligoamines with fluorescent properties. Part A: Fluorescent bridged nitrogen functions.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1992 Apr; 325(4):235-9. PubMed ID: 1530456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIV: Branched aliphatic and alicyclic triamines and tetramines.
    Rehse K; Kesselhut A; Schein V; Leissring S
    Arch Pharm (Weinheim); 1991 Apr; 324(4):243-7. PubMed ID: 1863203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [H2-antihistaminics. 34. 1,3,4-Oxadiazol-2,5-diamines with H2-antagonistic activity].
    Krämer I; Szelenyi I; Schunack W
    Arch Pharm (Weinheim); 1987 Feb; 320(2):120-30. PubMed ID: 2883956
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXI: 4,4'-Alkylene-bis-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 May; 326(5):307-11. PubMed ID: 8328885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and H2-antagonistic action of 1,3,4-thiadiazole-2,5-diamines].
    Wegner K
    Arch Pharm (Weinheim); 1986 Jan; 319(1):85-8. PubMed ID: 2870698
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXII: Bisoxazol-, bisimidazol-, bisthiazol- and oligo-1,2,4-thiadiazolimines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Jul; 326(7):399-404. PubMed ID: 8357302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.